Trials / Completed
CompletedNCT00826098
Platelet Rich Plasma (PRP) in Total Knee Replacement
Platelet Rich Plasma (PRP) in Total Knee Replacement: A Prospective, Randomized, Single-blind, Single-center Clinical Study to Evaluate the Effect of Platelet Rich Plasma (PRP) on Short-term Patient Outcomes Following Total Knee Replacement
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- Exactech · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Clinical study to evaluate the effect of platelet rich plasma (PRP), a derivative of a patient's whole blood, on short-term patient outcomes following total knee replacement (TKR).
Detailed description
The purpose of this clinical study is to evaluate the effect of platelet rich plasma (PRP), a derivative of a patient's whole blood, on short-term patient outcomes following total knee replacement (TKR). The hypothesis is that change in short-term hemoglobin (Hgb) levels is less dramatic in patients who undergo TKR with the addition of PRP when compared to patients who undergo TKR without PRP.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Platelet Rich Plasma | Addition of PRP to total knee replacement procedure |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2011-06-01
- Completion
- 2013-02-01
- First posted
- 2009-01-21
- Last updated
- 2022-09-01
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00826098. Inclusion in this directory is not an endorsement.